Genomic Risk Classifiers in Prostate Cancer: Precise Tools Awaiting Clinical Standardization
GRCs for prostate cancer show promise but lack standardization, with usage patterns varying by income and geography in clinical practice.




We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
These cookies are needed for adding comments on this website.
Google Tag Manager simplifies the management of marketing tags on your website without code changes.